BioStem Technologies, Inc.
BSEM
$4.20
-$0.39-8.50%
OTC PK
| 09/30/2025 | 06/30/2025 | 09/30/2024 | 09/30/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 234.85% | -112.59% | 7.30% | 8.51% | 30.25% |
| Total Depreciation and Amortization | 27.16% | 15.49% | 11.07% | -29.98% | 95.09% |
| Total Amortization of Deferred Charges | -100.00% | -33.51% | 8.66% | -72.89% | 491.12% |
| Total Other Non-Cash Items | -39.74% | 21.98% | -274.60% | -25.59% | -150.03% |
| Change in Net Operating Assets | -234.86% | 240.29% | 416.78% | 197.53% | 231.08% |
| Cash from Operations | -143.95% | 33.10% | 49.01% | 48.35% | 50.09% |
| Capital Expenditure | -627.32% | -101.82% | 24.75% | 26.65% | 23.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -251.26% | -101.82% | -741.18% | -739.28% | -758.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 83.69% | -803.34% | 43.73% | 58.86% | 32.47% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 85.32% | -1,242.48% | 82.94% | 98.08% | 79.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -188.38% | 8.58% | 35.63% | 35.63% | 35.63% |